Company Filing History:
2 out of 443 
2 out of 8,373 
1 out of 2,963 
Years Active: 2022-2024
Title: Innovations of Jonathan Strecker
Introduction
Jonathan Strecker is a prominent inventor based in Cambridge, MA, known for his contributions to the field of nucleic acid editing. With a total of two patents, he has made significant strides in developing innovative systems and methods for gene modification.
Latest Patents
Strecker's latest patents include "Systems, methods, and compositions for targeted nucleic acid editing." This invention provides systems and methods for targeting and editing nucleic acids, utilizing engineered DNA-targeting systems that comprise a DNA-targeting Cpf1 protein, guide molecules, and adenosine deaminase proteins. Another notable patent is "CRISPR-associated transposase systems and methods of use thereof," which outlines systems and methods for targeted gene modification and nucleic acid editing, incorporating components of CRISPR systems and transposable elements.
Career Highlights
Throughout his career, Jonathan Strecker has worked with esteemed organizations such as the Broad Institute and the Massachusetts Institute of Technology. His work has been pivotal in advancing the understanding and application of gene editing technologies.
Collaborations
Strecker has collaborated with notable figures in the field, including Feng Zhang and David Benjamin Turitz Cox, contributing to groundbreaking research and innovations.
Conclusion
Jonathan Strecker's work in nucleic acid editing exemplifies the innovative spirit of modern science. His patents and collaborations continue to influence the landscape of genetic research and technology.